Skip to content
Disclosery

Skorpios Trust

Follow

13F filer, CIK 1869333, LIMASSOL, Cyprus

Skorpios Trust reported $76,327,017 across 2 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-05.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001123292-25-000035

Period
2024-12-31
Reported value
$76.3M
Holdings
2
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
STOKreduced-2,000,000-$22.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2024

Share positions as resolved from 13F-HR 0001123292-25-000035, largest first. % of portfolio is the value over $76,327,017, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 14,443,681 shares; 2024Q1: 14,443,681 shares; 2024Q2: 10,843,681 shares; 2024Q3: 8,906,181 shares; 2024Q4: 6,906,181 shares 6,906,181$76.2M99.8%-2,000,000Timeline
XBISPDR SERIES TRUSTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 1,686 shares; 2024Q1: 1,686 shares; 2024Q2: 1,686 shares; 2024Q3: 1,686 shares; 2024Q4: 1,686 shares 1,686$152K0.2%0Timeline

How Q4 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001123292-25-000035 base2025-02-05acceptance time not in the bulk data set